Literature DB >> 10931325

Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells.

K J Pederson1, S Pal, A J Vallis, D W Frank, J T Barbieri.   

Abstract

ExoS is a type III cytotoxin of Pseudomonas aeruginosa, which modulates two eukaryotic signalling pathways. The N-terminus (residues 1-234) is a GTPase activating protein (GAP) for RhoGTPases, while the C-terminus (residues 232-453) encodes an ADP-ribosyltransferase. Utilizing a series of N-terminal deletion peptides of ExoS and an epitope-tagged full-length ExoS, two independent domains have been identified within the N-terminus of ExoS that are involved in intracellular localization and expression of GAP activity. N-terminal peptides of ExoS localized to the perinuclear region of CHO cells, and a membrane localization domain was localized between residues 36 and 78 of ExoS. The capacity to elicit CHO cell rounding and express GAP activity resided within residues 90-234 of ExoS, which showed that membrane localization was not required to elicit actin reorganization. ExoS was present in CHO cells as a full-length form, which fractionated with membranes, and as an N-terminally processed fragment, which localized to the cytosol. Thus, ExoS localizes in eukaryotic cells to the perinuclear region and is processed to a soluble fragment, which possesses both the GAP and ADP-ribosyltransferase activities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931325     DOI: 10.1046/j.1365-2958.2000.01990.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  13 in total

1.  Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.

Authors:  Matthew J Riese; Joseph T Barbieri
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.

Authors:  Yue Zhang; Joseph T Barbieri
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.

Authors:  Rebecca Krall; Jianjun Sun; Kristin J Pederson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.

Authors:  Annette A Angus; David J Evans; Joseph T Barbieri; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

7.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

8.  Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function.

Authors:  J E Fraylick; J R La Rocque; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  c-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis.

Authors:  Jinghua Jia; Mounia Alaoui-El-Azher; Marie Chow; Timothy C Chambers; Henry Baker; Shouguang Jin
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.